Dr. Yung-Jue Bang, a world-renowned expert in clinical development of anti-cancer therapeutics, is highly regarded as a global authority in the field of clinical oncology for gastric cancer. He completed his undergraduate, master's, and doctoral programs at Seoul National University College of Medicine.

Over the past 30 years, Dr. Bang has accumulated outstanding achievements as a key investigator in numerous clinical trials of anticancer agents in the clinical field. He has served as Chairman of the Korean Cancer Association, the President of the Korean Cancer Study Group, the President of Seoul National University Hospital Biomedical Research Institute, Director of Seoul National University Hospital Clinical Trials Center, and Outside Director at SK Biopharmaceuticals

Dr. Bang has published over 500 articles in SCI-indexed international journals, and has been selected as a top 1% highly cited researcher by Clarivate. In recognition of his contribution, he has received various honors and awards, including the Order of Service Merit - Red Stripes, the Asan Award in Medicine, the Presidential Award by Ministry of Health and Welfare, Health Industry Technology Award (Presidential Award), Minister's Award for Knowledge Creation, and Kobe Foundation Award.

Dr. Jacqueline French serves as the Chief Medical/Innovation Officer of the Epilepsy Foundation, with extensive experience and expertise in epilepsy and neurology. Dr. French’s research is focused on the development of new treatments and methodologies for epilepsy.

She has been a principal investigator of various clinical trials for new epilepsy drugs over the past 20 years. Dr. French has served as the President of the American Epilepsy Society (AES) and was responsible for the development of new clinical trials and guidelines on the use of new epilepsy drugs. She is the recipient of numerous prestigious awards
and has authored over 300 articles and is the editor of three books.

Dr. French received a medical degree from the Brown University and completed her neurological residency at the Mount Sinai Hospital in New York and an epilepsy fellowship at the Mount Sinai Hospital and Yale University Hospital.

Dr. Steve Chung is the Professor of Neurology at the University of Arizona and Director of Epilepsy Program at the Banner University Medical Center in Phoenix AZ. For the past 8 years, he served as the Chairman of Neurology and Executive Director of Neuroscience Institute at the Banner University Medical Center.

He has also been elected as the Chair for AAN Epilepsy Section in 2020-2022 and is currently serving the American Epilepsy Society as the Chair of Corporate Advisory Committee. Dr. Chung earned his medical degree at the Northwestern University School
of Medicine and completed residency and epilepsy fellowship at the University
of California, San Francisco (UCSF).

His honors and awards include AAN Education & Research Foundation Award, AAN and University Teaching Awards (4 times), and he has been voted as Best Doctors of America every year since 2005. Dr. Chung has been a principal investigator for more than 60 clinical studies and authored more than 80 original articles.

Dr. Il Minn's research focuses on the development of cancer diagnosis and molecular genetic therapy using molecular imaging and nanotechnology. He has been an important figure in translating research into clinical applications by utilizing radioisotopes,
CAR-T Cell, and molecular genetics to better target and diagnose cancer.

He has also served as a board member of the Korean-American Scientists and Engineers Association (KSEA), strengthening and promoting partnerships between the Korean pharmaceutical industry and Korean-American scientists. Professor Il Minn received
his Ph.D. from the Pennsylvania State University and completed postdoctoral studies
at Johns Hopkins.